UK markets closed

Dechra Pharmaceuticals plc (DPH.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
3,616.00+182.00 (+5.30%)
At close: 04:45PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 3.78B
Enterprise value 3.97B
Trailing P/E 52.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.92
Price/book (mrq)5.91
Enterprise value/revenue 6.20
Enterprise value/EBITDA 33.83

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-23.59%
S&P500 52-week change 3-11.93%
52-week high 35,525.00
52-week low 331.08
50-day moving average 33,348.51
200-day moving average 34,246.92

Share statistics

Avg vol (3-month) 3366.63k
Avg vol (10-day) 3240.82k
Shares outstanding 5108.39M
Implied shares outstanding 6N/A
Float 8107.75M
% held by insiders 11.30%
% held by institutions 168.74%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.41
Forward annual dividend yield 41.18%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 30.01%
5-year average dividend yield 40.99
Payout ratio 460.47%
Dividend date 3N/A
Ex-dividend date 403 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 11.38%
Operating margin (ttm)16.25%

Management effectiveness

Return on assets (ttm)5.46%
Return on equity (ttm)11.53%

Income statement

Revenue (ttm)640.6M
Revenue per share (ttm)5.92
Quarterly revenue growth (yoy)10.90%
Gross profit (ttm)345.9M
EBITDA 140.1M
Net income avi to common (ttm)72.9M
Diluted EPS (ttm)0.67
Quarterly earnings growth (yoy)74.70%

Balance sheet

Total cash (mrq)123.7M
Total cash per share (mrq)1.14
Total debt (mrq)316.8M
Total debt/equity (mrq)49.57
Current ratio (mrq)2.91
Book value per share (mrq)5.90

Cash flow statement

Operating cash flow (ttm)119.1M
Levered free cash flow (ttm)60.89M